Home / Inspections / 808119

FDA Inspection 808119 — Boehringer Ingelheim Pharma GmbH & Co. KG

Boehringer Ingelheim Pharma GmbH & Co. KG — FEI 3002806556

The FDA completed an inspection of Boehringer Ingelheim Pharma GmbH & Co. KG on November 12, 2012 in Ingelheim am Rhein. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
November 12, 2012
Fiscal Year
2013
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Ingelheim am Rhein (Germany)

Facility

Other inspections at this facility

  • 1315938 (VAI Thu May 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1208521 (VAI Thu Oct 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1053519 (VAI Fri May 04 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 962108 (VAI Tue Mar 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 921540 (NAI Fri Jan 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources